Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
1988
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
1988
Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy
1995
Pathophysiology of Progressive Nephropathies
1998 Standout
Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study
1993
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetes
1988
An Overview of Renal Pathology in Insulin-Dependent Diabetes Mellitus in Relationship to Altered Glomerular Hemodynamics
1992
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
Many little things: one geneticist's view of complex diseases
2005 StandoutNobel
Urocortin-1 Infusion in Normal Humans
2004
Molecular Mechanisms of Human Hypertension
2001 Standout
Molecular basis of human hypertension: Role of angiotensinogen
1992 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study
1994
MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS
1988
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Comparative studies on species-specific reactivity between renin and angiotensinogen
1994
Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.
1988
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
1997 StandoutNobel
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Microalbuminuria and ACE inhibition in non-hypertensive diabetics
1990
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
1994 Standout
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Genetic Determination of Plasma Aldosterone Levels in Essential Hypertension
1998
Long-Term Complications of Diabetes Mellitus
1993 Standout
Rationale for Fixed-Dose Combinations in the Treatment of Hypertension
2002
Angiotensin Converting Enzyme Inhibitors and Progressive Renal Insufficiency
1989
Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study
1992
The hormone resistin links obesity to diabetes
2001 StandoutNature
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion
1996
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
The Hallmarks of Aging
2013 Standout
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Ghrelin: Structure and Function
2005 Standout
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
1998 Standout
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Chronic Kidney Disease
2016 Standout
Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus
1990
Effect of hydrocortisone on phenylephrine– mean arterial pressure dose-response relationship in septic shock
2000
Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock
2002 Standout
Inappropriate Sympathetic Activation at Onset of Septic Shock
1999
Prorenin and Other Large Molecular Weight Forms of Renin*
1980
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Medical management of nephropathy in type I diabetes mellitus
1995
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
1999 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases
2003 Standout
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
2001 StandoutNobel
Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
1993
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic hemodynamic evaluations
1983
Nicardipine Hydrochloride Injectable Phase IV Open-Label Clinical Trial: Study on the Anti-Hypertensive Effect and Safety of Nicardipine for Acute Aortic Dissection
2002
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
2006
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
Genetic Dissection of Complex Traits
1994 StandoutScience
Renin-Angiotensin-Aldosterone and Hypertension
1980
Renal injury from angiotensin II-mediated hypertension.
1992
Role of angiotensinogen in blood pressure homeostasis.
1982
Genetic control of blood pressure and the angiotensinogen locus.
1995 StandoutNobel
Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition
1992
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice.
1994 StandoutNobel
Structure, expression, and regulation of the murine renin genes.
1991
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel
Works of T T Guyenne being referenced
Low angiotensinogen levels are related to the severity and liver dysfunction of congestive heart failure: implications for renin measurements
1991
Rapid Measurement of Total and Active Renin: Plasma Concentrations During Acute and Sustained Converting Enzyme Inhibition with CGS 14824A
1987
Converting‐enzyme inhibition buffers the counter‐regulatory response to acute administration of nicardipine.
1987
DIRECT RADIOIMMUNOASSAY OF HUMAN RENIN
1979
Two-Site Direct Immunoassay Specific for Active Renin
1992
New monoclonal antibodies directed against human renin. Powerful tools for the investigation of the renin system.
1984
Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.
1987
Multiple forms of human renin. Purification and characterization.
1979
Direct immunometric assay of active renin in human plasma.
1985